{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:17:33Z","timestamp":1793319453131,"version":"4.5.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin resistance or failure to produce insulin. Patients with DM develop microvascular complications that include chronic kidney disease and retinopathy, and macrovascular complications that mainly consist in an accelerated and more severe atherosclerosis compared to the general population, increasing the risk of cardiovascular (CV) events, such as stroke or myocardial infarction by 2- to 4-fold. DM is commonly associated with a low-grade chronic inflammation that is a known causal factor in its development and its complications. Moreover, it is now well-established that inflammation and immune cells play a major role in both atherosclerosis genesis and progression, as well as in CV event occurrence. In this review, after a brief presentation of DM physiopathology and its macrovascular complications, we will describe the immune system dysregulation present in patients with type 1 or type 2 diabetes and discuss its role in DM cardiovascular complications development. More specifically, we will review the metabolic changes and aberrant activation that occur in the immune cells driving the chronic inflammation through cytokine and chemokine secretion, thus promoting atherosclerosis onset and progression in a DM context. Finally, we will discuss how genetics and recent systemic approaches bring new insights into the mechanisms behind these inflammatory dysregulations and pave the way toward precision medicine.<\/jats:p>","DOI":"10.3389\/fcvm.2022.991716","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:07:48Z","timestamp":1664424468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications"],"prefix":"10.3389","volume":"9","author":[{"given":"Diane","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Vandiedonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Prac."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc22-Sint","article-title":"Introduction: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00002727-200404000-00003","article-title":"Pathophysiology of diabetes mellitus","volume":"27","author":"Guthrie","year":"2004","journal-title":"Crit Care Nurs Q."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1021\/jm0306273","article-title":"Diabetes mellitus: pathogenesis and treatment strategies","volume":"47","author":"Skyler","year":"2004","journal-title":"J Med Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2337\/diacare.2.2.120","article-title":"Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study","volume":"2","author":"Kannel","year":"1979","journal-title":"Diabetes Care."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00125-021-05640-y","article-title":"Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings","volume":"65","author":"Dziopa","year":"2022","journal-title":"Diabetologia."},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity."},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat Rev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.4049\/jimmunol.0900576","article-title":"Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells","volume":"183","author":"Bradshaw","year":"2009","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2013.00415","article-title":"Dendritic cell subsets in type 1 diabetes: friend or foe?","volume":"4","author":"Morel","year":"2013","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"666795","DOI":"10.3389\/fendo.2021.666795","article-title":"Islet-resident dendritic cells and macrophages in type 1 diabetes: in search of bigfoot's print","volume":"12","author":"Zirpel","year":"2021","journal-title":"Front Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/353260a0","article-title":"Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice","volume":"353","author":"Garchon","year":"1991","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/MED.0000000000000485","article-title":"Neutrophils and type 1 diabetes: current knowledge and suggested future directions","volume":"26","author":"Battaglia","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obesity."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e122146","DOI":"10.1172\/jci.insight.122146","article-title":"Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes","volume":"3","author":"Vecchio","year":"2018","journal-title":"JCI Insight."},{"key":"B19","doi-asserted-by":"publisher","first-page":"722979","DOI":"10.3389\/fimmu.2021.722979","article-title":"Natural killer cells as key mediators in type I diabetes immunopathology","volume":"12","author":"Gardner","year":"2021","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nri2449","article-title":"Nutrient sensing and inflammation in metabolic diseases","volume":"8","author":"Hotamisligil","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/MCB.00192-09","article-title":"Hypoxia-inducible factor 1\u03b1 induces fibrosis and insulin resistance in white adipose tissue","volume":"29","author":"Halberg","year":"2009","journal-title":"Mol Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-019-0870-9","article-title":"Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation","volume":"18","author":"Randeria","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced \u03b2 cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J Clin Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2008.04.009","article-title":"Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease","volume":"136","author":"Oliveira RTD","year":"2009","journal-title":"Int J Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science."},{"key":"B28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1038\/s41598-017-07923-0","article-title":"Macrophage JAK2 deficiency protects against high-fat diet-induced inflammation","volume":"7","author":"Desai","year":"2017","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1134\/S0006297916110134","article-title":"The role of cytokines in the development of atherosclerosis","volume":"81","author":"Fatkhullina","year":"2016","journal-title":"Biochemistry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCULATIONAHA.119.042863","article-title":"Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells","volume":"142","author":"Wolf","year":"2020","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41569-018-0106-9","article-title":"The role of B cells in atherosclerosis","volume":"16","author":"Sage","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2004.04.027","article-title":"Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques","volume":"176","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo","year":"2004","journal-title":"Circul J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/2047487313514894","article-title":"Adiponectin, type 2 diabetes and cardiovascular risk","volume":"22","author":"Lindberg","year":"2015","journal-title":"Eur J Prev Cardiolog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.5551\/jat.59386","article-title":"Coronary artery calcium score predicts long-term cardiovascular outcomes in asymptomatic patients with type 2 diabetes","volume":"28","author":"Lei","year":"2021","journal-title":"J Atheroscler Thromb."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00125-022-05698-2","article-title":"Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications study","volume":"65","author":"Soulimane","year":"2022","journal-title":"Diabetologia."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/01.CIR.93.12.2089","article-title":"Silent myocardial ischemia in patients with diabetes mellitus","volume":"93","author":"Chiariello","year":"1996","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-Segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science."},{"key":"B55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"191ra82","DOI":"10.1126\/scitranslmed.3006103","article-title":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8+ T cells in type 1 diabetes","volume":"5","author":"Roep","year":"2013","journal-title":"Sci Transl Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2337\/dc09-0054","article-title":"Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study","volume":"32","author":"Mastrandrea","year":"2009","journal-title":"Diabetes Care."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013","journal-title":"Lancet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4239\/wjd.v5.i2.89","article-title":"New insights into insulin: the anti-inflammatory effect and its clinical relevance","volume":"5","author":"Sun","year":"2014","journal-title":"World J Diabetes."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-inflammatory effects of GLP-1-based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.18632\/aging.102175","article-title":"The anti-inflammatory effects of SGLT inhibitors","volume":"11","author":"Garc\u00eda-Ropero","year":"2019","journal-title":"Aging."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcvm.2020.00010","article-title":"Monocytes and macrophages as protagonists in vascular complications of diabetes","volume":"7","author":"Kanter","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine","year":"2008","journal-title":"Clin Transl Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention and management of diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nyas.13462","article-title":"Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk","volume":"1402","author":"Barrett","year":"2017","journal-title":"Ann N Y Acad Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.diabres.2014.03.012","article-title":"Residual dysglycemia when at target HbA(1c) of 7% (53mmol\/mol) in persons with type 2 diabetes","volume":"104","author":"Monnier","year":"2014","journal-title":"Diabetes Res Clin Pract."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6S9","DOI":"10.1016\/S1262-3636(16)30003-9","article-title":"Postprandial and basal hyperglycaemia in type 2 diabetes: contributions to overall glucose exposure and diabetic complications","volume":"41","author":"Monnier","year":"2015","journal-title":"Diabetes Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.120.316653","article-title":"Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis","volume":"127","author":"Flynn","year":"2020","journal-title":"Circ Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation."},{"key":"B72","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: a model of immune dysregulation","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ng0397-293","article-title":"The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes","volume":"15","author":"Pugliese","year":"1997","journal-title":"Nat Genet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0397-289","article-title":"Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus","volume":"15","author":"Vafiadis","year":"1997","journal-title":"Nat Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6494795","DOI":"10.1155\/2017\/6494795","article-title":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation","volume":"2017","author":"Xia","year":"2017","journal-title":"J Diabetes Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/10408363.2015.1050714","article-title":"Vascular adhesion protein-1: role in human pathology and application as a biomarker","volume":"52","author":"Pannecoeck","year":"2015","journal-title":"Crit Rev Clin Lab Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/ATVBAHA.111.238030","article-title":"Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations","volume":"32","author":"Aalto","year":"2012","journal-title":"ATVB."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0002-9440(10)64501-4","article-title":"Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes","volume":"161","author":"Salmi","year":"2002","journal-title":"Am J Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00125-004-1346-2","article-title":"Adipocytes release a soluble form of VAP-1\/SSAO by a metalloprotease-dependent process and in a regulated manner","volume":"47","author":"Abella","year":"2004","journal-title":"Diabetologia."},{"key":"B83","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2337\/db10-0607","article-title":"Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes","volume":"60","author":"Li","year":"2011","journal-title":"Diabetes."},{"key":"B84","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","article-title":"Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory","volume":"77","author":"Giulietti","year":"2007","journal-title":"Diabetes Res Clin Pract."},{"key":"B87","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2337\/diabetes.55.03.06.db05-1417","article-title":"Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes","volume":"55","author":"Devaraj","year":"2006","journal-title":"Diabetes."},{"key":"B88","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care."},{"key":"B89","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.2337\/db07-0784","article-title":"Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications","volume":"56","author":"Devaraj","year":"2007","journal-title":"Diabetes."},{"key":"B91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/EC-17-0273","article-title":"Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes","volume":"7","author":"Zaharieva","year":"2018","journal-title":"Endocr Connect."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.2337\/diacare.28.12.2890","article-title":"Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes","volume":"28","author":"Nakamura","year":"2005","journal-title":"Diabetes Care."},{"key":"B93","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1475-2840-7-29","article-title":"The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes","volume":"7","author":"Meerwaldt","year":"2008","journal-title":"Cardiovasc Diabetol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1172\/JCI127308","article-title":"Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes","volume":"129","author":"Kanter","year":"2019","journal-title":"J Clin Invest."},{"key":"B95","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jcem-61-2-335","article-title":"Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages","volume":"61","author":"Kraemer","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1161\/CIRCULATIONAHA.107.741314","article-title":"Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus","volume":"117","author":"Mauldin","year":"2008","journal-title":"Circulation."},{"key":"B97","doi-asserted-by":"publisher","first-page":"21216","DOI":"10.1074\/jbc.M510952200","article-title":"Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation","volume":"281","author":"Mauldin","year":"2006","journal-title":"J Biol Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1073\/pnas.1111600109","article-title":"Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1","volume":"109","author":"Kanter","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.109.199570","article-title":"Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet","volume":"105","author":"Li","year":"2009","journal-title":"Circ Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.4049\/jimmunol.1800002","article-title":"Myeloid Slc2a1-deficient murine model revealed macrophage activation and metabolic phenotype are fueled by GLUT1","volume":"202","author":"Freemerman","year":"2019","journal-title":"J Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.febslet.2013.05.053","article-title":"High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation","volume":"587","author":"Joshi","year":"2013","journal-title":"FEBS Lett."},{"key":"B102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2337\/diab.22.6.429","article-title":"Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus","volume":"22","author":"Singal","year":"1973","journal-title":"Diabetes."},{"key":"B104","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature."},{"key":"B106","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/cvr\/cvy084","article-title":"A decade of genome-wide association studies for coronary artery disease: the challenges ahead","volume":"114","author":"Erdmann","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41588-020-0705-3","article-title":"Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease","volume":"52","author":"Koyama","year":"2020","journal-title":"Nat Genet."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","article-title":"Identification of type 2 diabetes loci in 433,540 East Asian individuals","volume":"582","author":"Spracklen","year":"2020","journal-title":"Nature."},{"key":"B112","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature."},{"key":"B113","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature."},{"key":"B114","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajhg.2018.11.006","article-title":"Human-disease phenotype map derived from PheWAS across 38,682 individuals","volume":"104","author":"Verma","year":"2019","journal-title":"Am J Human Genet."},{"key":"B115","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1101\/19012690","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet."},{"key":"B116","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B117","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1194\/jlr.P120001000","article-title":"Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study","volume":"62","author":"Thomas","year":"2021","journal-title":"J Lipid Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e58361","DOI":"10.7554\/eLife.58361","article-title":"A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease","volume":"10","author":"Zhao","year":"2021","journal-title":"Elife."},{"key":"B119","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cmet.2022.03.011","article-title":"Evaluating human genetic support for hypothesized metabolic disease genes","volume":"34","author":"Dornbos","year":"2022","journal-title":"Cell Metab."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy314.","article-title":"Shared genetic risk contributes to type 1 and type 2 diabetes etiology","author":"Aylward","year":"2018","journal-title":"Human Mol Genet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s00125-021-05428-0","article-title":"Analysis of overlapping genetic association in type 1 and type 2 diabetes","volume":"64","author":"Inshaw","year":"2021","journal-title":"Diabetologia."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet."},{"key":"B124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature18642","article-title":"The genetic architecture of type 2 diabetes","volume":"536","author":"Fuchsberger","year":"2016","journal-title":"Nature."},{"key":"B125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-019-1231-2","article-title":"Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls","volume":"570","author":"Flannick","year":"2019","journal-title":"Nature."},{"key":"B126","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/cge.13187","article-title":"Genetic association of molecular traits: a help to identify causative variants in complex diseases","volume":"93","author":"Vandiedonck","year":"2018","journal-title":"Clin Genet."},{"key":"B127","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.2337\/db15-1690","article-title":"Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pmed.1002548","article-title":"Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children","volume":"15","author":"Bonifacio","year":"2018","journal-title":"PLoS Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/jmedgenet-2018-105532","article-title":"Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study","volume":"56","author":"Beyerlein","year":"2019","journal-title":"J Med Genet."},{"key":"B134","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat Genet."},{"key":"B135","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ajhg.2017.03.004","article-title":"Human demographic history impacts genetic risk prediction across diverse populations","volume":"100","author":"Martin","year":"2017","journal-title":"Am J Human Genet."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/er.2019-00088","article-title":"Genetic risk scores for diabetes diagnosis and precision medicine","volume":"40","author":"Udler","year":"2019","journal-title":"Endocr Rev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"Nair","year":"2022","journal-title":"Nat Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCULATIONAHA.118.039357","article-title":"Blood leukocyte DNA methylation predicts risk of future myocardial infarction and coronary heart disease","volume":"140","author":"Agha","year":"2019","journal-title":"Circulation."},{"key":"B139","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41467-017-00517-4","article-title":"Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41588-019-0514-8","article-title":"HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype","volume":"51","author":"Malhotra","year":"2019","journal-title":"Nat Genet."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41588-019-0493-9","article-title":"Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases","volume":"51","author":"Soskic","year":"2019","journal-title":"Nat Genet."},{"key":"B142","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat Commun."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41588-019-0457-0","article-title":"Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes","volume":"51","author":"Miguel-Escalada","year":"2019","journal-title":"Nat Genet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41588-022-01025-y","article-title":"Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases","volume":"54","author":"Kundu","year":"2022","journal-title":"Nat Genet."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41588-018-0216-7","article-title":"Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes","volume":"50","author":"Westra","year":"2018","journal-title":"Nat Genet."},{"key":"B146","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","article-title":"Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases","volume":"184","author":"Ota","year":"2021","journal-title":"Cell."},{"key":"B147","doi-asserted-by":"publisher","first-page":"109807","DOI":"10.1016\/j.celrep.2021.109807","article-title":"TIGER: the gene expression regulatory variation landscape of human pancreatic islets","volume":"37","author":"Alonso","year":"2021","journal-title":"Cell Rep."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/CIRCRESAHA.120.317415","article-title":"Genetic regulation of atherosclerosis-relevant phenotypes in human vascular smooth muscle cells","volume":"127","author":"Aherrahrou","year":"2020","journal-title":"Circul Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ajhg.2020.04.008","article-title":"Systems genetics in human endothelial cells identifies non-coding variants modifying enhancers, expression, and complex disease traits","volume":"106","author":"Stolze","year":"2020","journal-title":"Am J Human Genet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","article-title":"Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies","volume":"54","author":"Zhang","year":"2022","journal-title":"Nat Genet."},{"key":"B151","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1038\/s41467-021-27164-0","article-title":"Synergistic insights into human health from aptamer- and antibody-based proteomic profiling","volume":"12","author":"Pietzner","year":"2021","journal-title":"Nat Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","article-title":"The polygenic and monogenic basis of blood traits and diseases","volume":"182","author":"Vuckovic","year":"2020","journal-title":"Cell."},{"key":"B154","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.aad6970","article-title":"Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases","volume":"353","author":"Franz\u00e9n","year":"2016","journal-title":"Science."},{"key":"B155","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41588-022-01069-0","article-title":"Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk","volume":"54","author":"Turner","year":"2022","journal-title":"Nat Genet."},{"key":"B156","doi-asserted-by":"publisher","first-page":"eabf3041","DOI":"10.1126\/science.abf3041","article-title":"Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease","volume":"376","author":"Yazar","year":"2022","journal-title":"Science."},{"key":"B157","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s44161-021-00009-1","article-title":"A mechanistic framework for cardiometabolic and coronary artery diseases","volume":"1","author":"Koplev","year":"2022","journal-title":"Nat Cardiovasc Res."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","article-title":"An expanded view of complex traits: from polygenic to omnigenic","volume":"169","author":"Boyle","year":"2017","journal-title":"Cell."},{"key":"B159","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.991716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:07:53Z","timestamp":1664424473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.991716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":160,"alternative-id":["10.3389\/fcvm.2022.991716"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.991716","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"991716"}}